This story was originally published on Manufacturing Dive. To receive daily news and insights, subscribe to our free daily Manufacturing Dive newsletter. Dive Brief: Eli Lilly said it will build a $6.5 billion factory in Houston focused on manufacturing the company’s first obesity pill and other small molecule medicines. The 236-acre site will produce active pharmaceutical ingredients, among them orforglipron, a small, oral GLP-1 receptor agonist, according to a news release. The molecule agonist is up f ...

Switching gears, Eli Lily surging almost 6%. It led the S&P 500 today. Their obesity pill cleared yet another late stage trial.Patients with type 2 diabetes and obesity losing an average 10 a.5% of their body weight after 72 weeks is on the highest dose. For more on what may come next, city research managing director Jeff Meechum joining us now. Jeff, great to have you on the show.What did these results mean for Lily. >> Awesome. Thanks for having me, Brian.Um, yes. So, the results here are derisking from t ...

Shares of Eli Liy are now down over 14 plus%. That is uh well more than where uh the stock opened this morning. This follows what is being seen as disappointing data for its upcoming pill to treat obesity.Let's get to Angelica Peebles for more. Angelica, this is uh this is getting pretty serious in terms of a market cap loss now. Yeah, David, quite a big reaction today and that's because of the data like you talked about.So, let's get into the numbers. people lost about 12% of their body weight after a litt ...

news uh that we've I guess been waiting for from Eli Liy. Got a look at the stock. Uh although we'll show you that Angelica Peeles that's here and joins us now, but uh as you're talking, we should take a quick look at the uh early morning action in the shares.But take it away. >> Yeah, that early morning action not good. The stock down about 6% right now and that's after we got this highly anticipated data on its obesity pill and clearly there's some disappointment.So let's go through the numbers. people lo ...